Trial Design

Add ONTARGET® Trial Programme to My Alerts (what's this?)

Print | Send to a friend
  • Prospective
  • Randomised
  • Double-blind
  • Placebo-controlled
  • Multicentre
  • Multinational
  • 5.5-year treatment regimen

title

 

Study Sponsor:            Boehringer Ingelheim GmbH

Study Co-Sponsors:   Bayer Schering Pharma and GlaxoSmithKline

References

Toolbox

Calendar

Tools and Downloads

My Alerts

You will shortly be able to create your own personal alerts service bringing the latest ONTARGET® news and updates direct to your inbox. Watch this space for more information.